Abstract Usnea longissima has a long history of use as a traditional medicine. Several bioactive compounds, primarily belonging to the polyketide family, have been isolated from U. longissima. However, the genes for the biosynthesis of these compounds are yet to be identified. In the present study, three different types of non-reducing polyketide synthases (UlPKS2, UlPKS4, and UlPKS6) were identified from a cultured lichen-forming fungus of U. longissima. Phylogenetic analysis of product template domains showed that UlPKS2 and UlPKS4 belong to group IV, which includes the non-reducing polyketide synthases with an methyltransferase (MeT) domain that are involved in methylorcinol-based compound synthesis; UlPKS6 was found to belong to group I, which includes the non-reducing polyketide synthases that synthesize single aromatic ring polyketides, such as orsellinic acid. Reverse transcriptase-PCR analysis demonstrated that UlPKS2 and UlPKS4 were upregulated by sucrose; UlPKS6 was downregulated by asparagine, glycine, and alanine.
Mycobiology
Three New Non-reducing Polyketide Synthase Genes from the Lichen-Forming Fungus Usnea longissima
Lichens are stable and self-supporting symbiotic organisms between fungi (mycobiont) and photoautotrophic algal partners (photobiont), namely green algae and/or cyanobacteria [1] . Lichen-forming fungi (LFF) have been found to produce a wide array of secondary metabolites. These secondary metabolites have shown an impressive range of biological activities, including antibiotic, antifungal, anti-protozoan, anti-human immunodeficiency virus, anticancer, and antioxidant activities [2] [3] [4] [5] . Accordingly, LFF show huge potential value for discovery of new drugs [6] [7] [8] [9] .
Fungal polyketide synthases (PKSs) primarily belong to iterative type I PKSs, which have β-ketoacyl synthase (KS), acyl transferase (AT), and acyl carrier protein (ACP) domains. Specific iterative type I PKSs may also contain starter units: ACP transacylase (SAT), product template (PT), ketoreductase, dehydratase (DH), enoyl reductase, thioesterase (TE), or C-methyltransferase (CMeT) domains. Type I fungal PKSs have been divided into three classes according to the variation in these optional processing domains: aromatic or non-reducing PKS (NR-PKS), partially reducing PKS, and highly reducing PKS [10, 11] . The NRPKSs can be divided into five classes according to the PT domains that are embedded in the multidomain NR-PKSs, which mediate the regioselective cyclization of the highly reactive polyketide backbones and dictate the final structure of the products [12] .
Most unique lichen secondary metabolites, such as depsides, depsidones, depsones, and dibenzofurans, are derived from the polyketide pathway [13] . Among them, depsides consist of two or occasionally three aromatic rings joined by ester linkages; the depsidones have an extra ether linkage between the rings. Lichen depsides and depsidones can be grouped into either a β-orcinol or orcinol series, depending on the presence of a CH 3 on the C 3 carbon of their rings [14] . Their non-reduced backbones indicate that the corresponding PKSs belong to a subgroup of NRPKSs [11] . The PKS genes of β-orcinols are similar and could belong to the NR-PKS group, with a methyltransferase (MeT) domain [14, 15] . To date, only a few lichen PKSs, mostly NR-PKSs, have been analyzed [14] [15] [16] [17] [18] [19] .
In a previous study, we reported two PKSs, a NR-PKS and a reducing PKS, from U. longissima [20, 21] . In the present study, we report three additional novel NR-PKSs, which may be involved in the biosynthesis of orcinol and β-orcinol depside or depsidone.
MATERIALS AND METHODS
PCR amplification of the KS domain. U. longissima LFF used in this study had been previously identified and deposited at the Korea Lichen and Allied Bioresearch Center, Sunchon National University [20] . The LFF was grown and maintained in malt-yeast (MY) medium (Difco, Detroit, MI, USA). Total DNA was isolated from the U. longissima LFF using a DNeasy Plant Mini Kit (Qiagen, Carlsbad, CA, USA). A series of degenerate primers (Table 1) were used for KS fragment amplification, using touchdown PCR cycling conditions. The PCR product was subcloned into the pGEM-T vector (Promega, Madison, WI, USA). Colonies with the putative inserted fragment were picked for sequencing.
Genomic library screening. The specific primers (Fnrks57 and Rnrks57; Flc3551 and Rlc3551; Fmtc141 and Rmtc141; shown in Table 1 [22] using Aspergillus as the matrix (http://linux1.softberry.com). The putative function of these ORFs was determined using a basic local alignment search tool (BLAST). The conserved domain was confirmed using the CDD-Search/PRS-BLAST (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).
Phylogenetic analyses. The PT domain of the NR-PKS from U. longissima was aligned with 35 fungal NR-PKS sequences retrieved from GenBank. The alignment was analyzed using ClustalW embedded in the MEGA 4.0.2 program (http://www.megasoftware.net/). To obtain a confidence value for the aligned sequence dataset, bootstrap analysis with 100 replicates was performed using the MEGA 4.0.2 program. A phylogenetic tree was constructed using the minimum evolution method.
Reverse transcription-polymerase chain reaction. Mycelia of U. longissima LFF (100 mg) were ground into powder after freezing in liquid nitrogen. RNA was then extracted using an RNeasy Plant Mini Kit (Qiagen). SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) was used for first-strand cDNA synthesis. The full cDNA of U. longissima PKS was amplified using Table 1 primers designed using the predicted mRNA sequence (Table 1) .
Expression patterns of NR-PKS transcripts in U.
longissima. U. longissima LFF were ground to homogeneity and incubated on MY solid medium. After 2 months of culture at 15 o C, the mycelia were harvested, and then transferred into MY basal medium containing 2% or 10% (W/V) inositol, mannitol, sorbitol, sucrose, glucose, or fructose. Amino acid media were also prepared by adding 0.2% and 1% (W/V) glutamine, asparagine, glycine, or alanine to the MY basal medium. The U. longissima LFF were cultured for two months on the various media. RNA was extracted from the samples using an RNeasy Plant Mini Kit (Qiagen). One microgram of total RNA from each sample was used for first-strand cDNA synthesis, which was performed using SuperScript II reverse transcriptase (Invitrogen). Specific primers (Table 1) were used to detect NR-PKS gene expression, with tubulin as the control. All the PCR reactions were conducted using the following reaction mixtures: 1 µL cDNA, 2 µL primer mixture, 1 µL Accupower PCR PreMix (Bioneer, Daejoen, Korea), and 16 µL distilled water. Reverse transcription-polymerase chain reaction (RT-PCR) experiments were repeated three times for each of the three independent replicates.
RESULTS
Isolation of the KS domain using degenerate primers. PCR of LFF genomic DNA with degenerate primers yielded several bands (Fig. 1) , and the PCR products were subsequently cloned and sequenced. Of the clones, three contained a partial KS domain sequence (NRks57, LC3551, and MTc14). The NRks57 clone was obtained using degenerate primers NR3KSF and NR3KSR. The closest NRks57 homologue found in the GenBank database was a putative NR-PKS KS domain fragment from Coccidioides posadasii (87% identity; GenBank accession No. EFW20973.1). The LC3551 clone was obtained using degenerate primers LC3 and LC5c. The closest LC3551 homologue was a putative NR-PKS KS domain fragment from Mycosphaerella populorum (71% identity; GenBank accession No. EMF17516.1). The MTc14 clone was obtained using degenerate primers Fcmet and RcmetL2. The closest MTc14 homologue was a putative NR-PKS KS domain fragment from Pertusaria pertusa (54% identity; GenBank accession No. ABQ11392.1). All the clones belonged to the group of NR-PKSs.
Domain organization of PKS genes.
An initial U. longissima LFF genomic library was constructed in pEpiFOS (Epicentre). After screening of the genomic library, a clone containing a complete PKS fragment was chosen for further sequencing. A total of three PKSs, UlPKS2, UlPKS4, and UlPKS6, were obtained from the sequence analysis.
UlPKS2 was a 6,290-bp gene encoding a 1,788-amino acid protein. The presence of six introns was confirmed by RT-PCR (Table 2) . Six catalytic domains were identified in UlPKS2 by conserved motif analysis. These domains were KS, AT, PT, two ACP, and a TE domain. The domains were in the following order: KS/AT/PT/ACP/ACP/TE ( Table 2) . Comparison of UlPKS2 with corresponding domains of other fungal PKSs showed conservation of active site residues in the KS (DTACSASAV), AT (GHSFGQ), PT (GHEVVDQTLCPAS), ACP1 (NIDSLLATE) ACP2 (GVDSLLATE), and TE (GWSSGGHL) domains. UlPKS2 was deposited in GenBank with the accession No. JX232185.
UlPKS4, which encoded a 2441-amino acid protein, was confirmed to have seven exons by RT-PCR (Table 2 ). UlPKS4 Table 2 ). UlPKS6 has the following conserved active site residues: KS (ACSARTSYSL), AT (YGFHSAQ), PT (GHLVDNTAIC), DH (GLSHRLQRP), ACP (GLDSLMSIA), and TE (GGWSAGA). UlPKS6 was deposited in GenBank with the accession No. JX232188.
Phylogenetic analysis of NR-PKSs.
The amino acid sequence of the PT domain of the three NR-PKSs from U. longissima and several fungal NR-PKSs were used to generate multiple alignments and phylogenetic trees (Fig.  2) . UlPKS2 was grouped with Penicillium brevicompactum MpaC, which is involved in 5-methylorsellinic acid biosynthesis, and UlPKS4 was grouped with Acremonium strictum MoS, which is involved in 3-methylorcinaldehyde biosynthesis. These PKSs formed an independent clade, group VI. UlPKS6 was grouped with Cladonia grayi PKS16 and Aspergillus nidulans AN7909, and these three sequences formed an independent clade that is closely related to the NR-PKSs, group I [12] . These PKSs synthesize compounds containing a single aromatic ring, similar to orsellinic acid synthase AN7909 from A. nidulans and C. grayi PKS16, which is involved in orcinol depside biosynthesis.
Expression patterns of PKS transcripts.
To confirm the functionality of the genes in the production of metabolites in intact LFF, U. longissima LFF were transferred to a media containing various carbon sources and amino acids. The expression of UlPKS2, UlPKS4, and UlPKS6 was evaluated under various nutrient conditions using RT-PCR. As shown in Fig. 3, although UIPKS2 was not expressed in most media, sucrose and fructose strongly induced UlPKS2 gene expression at higher concentrations (10%). UlPKS4 was expressed at a very low level in the basic MY medium. The amino acids glutamine, asparagine, and glycine had very slight effects on basal UlPKS4 expression, but alanine strongly upregulated UlPKS4 expression at higher concentrations (1%). Furthermore, inositol, mannitol, and glucose only slightly induced UlPKS4 gene expression, but sorbitol, sucrose, and fructose strongly induced UlPKS4 gene expression at higher concentrations (10%). UlPKS6 was expressed at high levels in the basic MY medium, in media with a carbon source (inositol, mannitol, sorbitol, sucrose, glucose, and fructose), and in glutamine media. Asparagine, glycine, and alanine slightly downregulated UlPKS6 expression.
DISCUSSION
U. longissima has a long history of use as a traditional medicine in China, India, Turkey, Canada, and Europe [23] . Several bioactive compounds that are synthesized via the polyketide pathway have been isolated from U. longissima (Fig. 4) [24, 25] , including β-orcinol-type despides: atranorin, diffractaic acid; a β-orcinol-type depsidone: salazinic acid; an orcinol-type despide: evernic acid; a dibenzofuran: usnic acid; and an anthraquinone: longissimausnone. Similar to other lichens, U. longissima is a stable and selfsupporting symbiotic organism between a fungus and its photoautotrophic algal partners, and its secondary metabolites are mainly produced by the fungal component. However, in nature, lichens are composed of not only the mycobiont, algae, and cyanobacteria, but also include endolichenic fungi and lichenicolous fungi [26, 27] . The mixture of symbiotic organisms may provide imprecise information during the genetic analysis of LFF. Therefore, we isolated and cultured the LFF of U. longissima, using the Yamamoto method [28] , to acquire genetic information.
In the present study, we investigated three NR-PKS genes from the LFF of U. longissima. Three entire NR-PKS genes (UlPKS2, 6,290 bp; UlPKS4, 7,927 bp; and UlPKS6, 6,780 bp) were identified via the screening of a Fosmid genomic library. UlPKS4 domain analysis revealed the presence of KS, AT, PT, ACP, MeT, and TE domains. The domain architecture of the UlPKS4 protein has also been identified in other non-lichenized fungi, such as Penicillium brevicompactum, in which MpaC is involved in 5-methylorsellinic acid synthesis [29] , and Acremonium strictum, in which MOS is involved in methylorcinaldehyde synthesis [30] . All of the identified genes had the domain organization KS-AT-PT-ACP-MeT-TE. Phylogenetic analyses using the amino acid sequence of the PT domains revealed that both UlPKS2 and UlPKS4 belonged to group VI (Fig. 2) , which also included Penicillium brevicompactum MpaC, Acremonium strictum MOS, and Xanthoparmelia semiviridis PKS1. All of these genes possessed a MeT domain. β-Orcinol lichen compounds require a NR-PKS with a CMeT domain [14, 15] . This suggested that UlPKS4 may be involved in â-orcinol depside or depsidone synthesis. However, domain analysis of UlPKS2 revealed the presence of the KS, AT, PT, ACP, and TE domains, but no MeT domain, which may have been lost during the course of evolution [11] .
Phylogenetic analyses using the amino acid sequence of the PT domains revealed a close relationship between UlPKS6 and the NR-PKS from Cladonia grayi (38% sequence identity; accession No. ADM79459.1), followed by A. nidulans (35% sequence identity; accession No. XP_681178). All of these PKSs fell into group I (Fig. 2) . Group I included the C. grayi PKS16, involved in the production of depside grayanic acid [11] , orsellinic acid synthase AN7909 from A. nidulans [31] , and the NR-PKSs that are involved in the synthesis of orcinol-based resorcylic acid lactones, including the zearalenone PKS13, the hypothemycin Hpm3 [32] , and the radicicol RDC1/RADS2 [33] . However, comparison of the domain organization of the group I PKSs showed that UlPKS6 possessed an extra DH domain, suggesting that UlPKS6 is a novel NR-PKS producing orcinol-based metabolites.
Carbon and nitrogen sources influence secondary metabolism in cultured LFF [18, 34, 35] , and also influence the expression of biosynthetic genes. We analyzed gene expression in different nutrient conditions. Expression patterns showed that carbon-source media (inositol, mannitol, sorbitol, sucrose, glucose, and fructose) did not alter basal U1PKS6 expression, but asparagines, glycine and alanine, slightly downregulated UlPKS6 expression. UlPKS4 expression varied across media. Glutamine, glycine, inositol, mannitol, and glucose slightly upregulated UlPKS4 expression. Sorbitol (10%), sucrose (10%), and alanine (1%) strongly induced UlPKS4 expression. UlPKS2 was not expressed in amino acid media and most carbon source media (inositol, mannitol, and sorbitol), and was only expressed strongly in sucrose medium (10%). UlPKS2, UlPKS4, and UlPKS6 showed different expression patterns, but all were strongly expressed by high concentration (10%) of sucrose. This response is similar to the role of sucrose in the osmotic activation of the acetate-polymevalonate pathway leading to polyketide production (divaricatic acid) in Evernia esorediosa and Ramalina subbreciuscula [34] . It suggests that sucrose and high osmotic culture conditions can activate the PKS pathway in LFF.
We reported three novel NR-PKSs from U. longissima, and predicted their function according to their domain composition and phylogenetic relationships. As no transformation system is currently available for LFF, future studies will focus on the heterologous expression of these NR-PKSs in other well-studied filamentous fungi, such as Aspergillus sp., to determine their functional characterization. Such studies will provide a basis for the sustainable application of lichen secondary metabolites in the pharmaceutical industry.
